Monthly cycles of methylperdnisolone in combination with interferon beta-1a IM are efficacious in the treatment of early relapsing-remitting multiple sclerosis. The MECOMBIN study.

Title:	Monthly cycles of methylperdnisolone in combination with interferon beta-1a IM are efficacious in the treatment of early relapsing-remitting multiple sclerosis. The MECOMBIN study.
Author(s):	Ravnborg, M. Sorensen, P. Andersson, M. Celius, E.G. Jongen, P.J.H. (145084973) Bartholome, E. Elovaara, I. Beer, K. Constantinescu, C.
Publication year:	2009
Document type:	Article / Letter to editor
Journal:	Multiple Sclerosis
ISSN:	1352-4585
Volume:	vol. 15
Issue:	iss. 9
Start page:	p. s14
End page:	p. s14
Subject:	DCN 2: Functional Neurogenomics
Organization:	Neurology UMCN Extern
Appears in Collections:	Academic bibliography

Please use this identifier to cite or link to this item: http://hdl.handle.net/2066/79668